Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight
Angioedema is swelling underneath the skin. It's usually a reaction to a trigger, such as a medicine or something you're allergic to. It is not normally serious, but it can be a recurring problem for some people and can very occasionally be life-threatening if it affects breathing.
DelveInsight's "Angioedema
Market Insights, Epidemiology, and Market Forecast-2032" report
delivers an in-depth understanding of the Angioedema, historical and forecasted
epidemiology as well as the Angioedema market trends in the United States, EU5
(Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Angioedema Market Report are:
·
HAE in the US has been observed with the maximum
number of diagnosed cases in the age-group 17 to below 65 years, followed by
those who belong to the age-group 12 to less than 17 years. DelveInsight’s
analysts have estimated that there were 882 cases diagnosed for the age group
17 to below 65 years in 2017, among the US population, which is predicted to
increase consistently throughout the study period.
·
Among the European countries, France had the
highest prevalent population of 1,346 cases, followed by the UK which had
prevalent population of 1,301 in 2017.
·
Type 1 HAE (98.73%) accounted for the majority
of Chinese HAE patients, while no type 3 HAE patient has been diagnosed in
China to date (Liu et al, 2019).
·
According to DelveInsight’s analysis, HAE is
more prominent in females in comparison to males.
View Report: https://www.delveinsight.com/report-store/angioedema-market
To know more details about
Angioedema Market Report,
Click here: https://www.delveinsight.com/sample-request/angioedema-market
Scope of the Angioedema
Market Report
- The
report covers the descriptive overview of Angioedema, explaining its
causes, signs and symptoms, pathophysiology, diagnosis and currently
available therapies
- Comprehensive
insight has been provided into the Angioedema epidemiology and treatment
in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Angioedema is provided, along with the assessment of new therapies, which
will have an impact on the current treatment landscape
- A
detailed review of the Angioedema market; historical and forecasted is
included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Angioedema market
View Report: https://www.delveinsight.com/report-store/angioedema-market
To know more details
of Angioedema Market Report,
Click here: https://www.delveinsight.com/report-store/angioedema-market
Some of Angioedema Drugs are:
·
Lanadelumab
·
C1 inhibitor concentrate (C1-esteraseremmer-N)
·
Icatibant
·
Omalizumab
·
KVD824
·
And Many Others
Some of the Angioedema Companies are:
·
Takeda
·
Shire Pharmaceuticals
·
Prothya Biosolutions
·
Novartis
·
KalVista Pharmaceuticals
·
And Many Others
View Report: https://www.delveinsight.com/report-store/angioedema-market
To know more details about
Angioedema Pipeline drugs
and Therapies, Click here: https://www.delveinsight.com/sample-request/angioedema-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Angioedema
3. Competitive
Intelligence Analysis for Angioedema
4. Angioedema:
Market Overview at a Glance
5. Angioedema:
Disease Background and Overview
6. Patient Journey
7. Angioedema
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9.
Angioedema Unmet Needs
10. Key Endpoints of
Angioedema Treatment
11.
Angioedema Marketed Products
12.
Angioedema Emerging Therapies
13. Angioedema:
Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Angioedema
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
View Report: https://www.delveinsight.com/report-store/angioedema-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research Firm focused exclusively on life sciences. It supports pharma
companies by providing end-to-end comprehensive solutions to improve their
performance.
·
Central Retinal Vein Occlusion Market
·
Microsatellite Stable Colorectal Cancer Market
·
Progressive Multifocal Leukoencephalopathy Market
·
Prosthetic
Joint Infection Market
·
Higher-Risk
Chronic Myelomonocytic Leukemia Market
·
Upper
Limb Hypertonia Market
·
X-linked
Retinitis Pigmentosa Market
·
Metachromatic
Leukodystrophy Market
·
Idiopathic
Membranous Nephropathy Market
·
Nevoid
Basal Cell Carcinoma Syndrome Market
·
Chronic
Refractory Cough Market
·
Cardiopulmonary
Bypass Equipment Market
·
Cardiac
Biomarkers Testing Devices Market
·
Epithelial
Ovarian Cancer Market
·
Surgical
Site Infection Ssi Market
·
Synchronous
Endometrial And Ovarian Carcinoma Market
·
Autosomal
Recessive Congenital Ichthyosis Market
·
Rituximab
Biosimilars Insight
·
Pain
Management Devices Market
·
Continuous
Renal Replacement Therapy Machines Market
·
Parkinsons
Disease Related Dementia Market
·
22q11.2
Deletion Syndrome Market
·
Pediatric
Growth Hormone Deficiency Pghd Market
·
Brain
Aneurysm Stents Market
Comments
Post a Comment